* Orgenesis Inc ORGS.OQ reported a quarterly adjusted loss
of 42 cents per share for the quarter ended in September. The
lone analyst forecast for the quarter was for a loss of 3 cents
per share.
* Revenue rose 401.8% to $8.68 million from a year ago;
analysts expected $9.00 million.
* Orgenesis Inc's reported EPS for the quarter was a loss of 42
cents.
* The mean earnings estimate of analysts had risen by
about 86.4% in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Orgenesis Inc shares had fallen by 3.2% this quarter and
gained 6.4% so far this year.
* The company reported a quarterly loss of $10.16 million.
* Wall Street's median 12-month price target for Orgenesis Inc
is $9.00
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated November 4 at 02:00 p.m.
All figures in US dollars unless otherwise stated